Vascular transplantation of Syrian hamster heart into Lewis rat: effect of brequinar, cyclosporine, cobra venom factor, and splenectomy.
Preclinical Research, Sandoz Pharma, Ltd, Basel, Switzerland.
H J
HJ
Schuurman
J
J
Joergensen
H
H
Kuipers
T
T
Meerloo
P
P
Lardelli
P
P
Hiestand
D H
DH
White
M H
MH
Schreier
D000714:Anastomosis, Surgical; D000818:Animals; D001012:Aorta, Abdominal / Q000601:surgery; D001713:Biphenyl Compounds / Q000627:therapeutic use; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use; D004546:Elapid Venoms / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000379:methods; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008647:Mesocricetus; D011651:Pulmonary Artery / Q000601:surgery; D051381:Rats; D011917:Rats, Inbred Lew; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000379:methods; D016042:Transplantation, Heterotopic; D014682:Vena Cava, Inferior / Q000601:surgery; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D004546:Elapid Venoms; D007166:Immunosuppressive Agents; C016310:cobra venom factor; C046943:brequinar; D011798:Quinaldines